Mark Slee

Flinders University

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Immunology Immunology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (25)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (25)

Ai-Lan Nguyen

University of Melbourne

AUSTRALIA

View details

Vilija Jokubaitis

MONASH UNIVERSITY

AUSTRALIA

View details

Lara Kular

Assistant Professor

Karolinska Institutet

SWEDEN

View details

Youichirou Ootsuka

Associate Professor

Flinders University

AUSTRALIA

View details

Luke Selth

Flinders University

AUSTRALIA

View details

Rebecca Ormsby

Flinders University

AUSTRALIA

View details

Justin Yehuda Garber

Clinical Senior Lecturer

University of Sydney

AUSTRALIA

View details

Marzena Pedrini

University of Western Australia

AUSTRALIA

View details

Brett Stringer

Flinders University

AUSTRALIA

View details

Giovanna De Luca

Multiple Sclerosis Centre Medical Coordinator (responsabile Centro SM con incarico di medio alta professionalità)

Ospedale San Raffaele

ITALY

View details

Eduardo Aguera-Morales

Profesor Asociado

Universidad de Córdoba

SPAIN

View details

Maria José Sá

Universidade da Beira Interior Faculdade de Ciências da Saúde

PORTUGAL

View details

Adil Harroud

McGill University

CANADA

View details

William Brown

University of Cambridge

UNITED KINGDOM

View details

Lars Alfredsson

Healthcare Provision, Stockholm County

SWEDEN

View details

Rodney Scott

Prof. of Medical Genetics

University of Newcastle Australia

AUSTRALIA

View details

Bruce V. Taylor

AUSTRALIA

View details

francesco patti

Professore Associato di Neurologia SSD Med 26

University of Catania

ITALY

View details

Alessandra Lugaresi

Associate Professor

ITALY

View details

Yi Chao Foong

University of Tasmania

AUSTRALIA

View details

Izanne Roos

University of Melbourne

AUSTRALIA

View details

Allan Kermode

University of Western Australia

AUSTRALIA

View details

Charles B. Malpas

AUSTRALIA

View details

William L Herring

Health Solutions

UNITED STATES

View details

Simon Conn

Professor

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mark Slee

Research Interests

Explore related searches

Contact this professor

Articles (25)

Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.

First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis.

Consensus recommendations on multiple sclerosis management in Australia and New Zealand

Consensus recommendations on multiple sclerosis management in Australia and New Zealand

Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.

Glucocorticoid-induced adrenal suppression

Minimising harm

The Efficacy, Adverse Effects and Economic Implications of Oral Versus Intravenous Methylprednisolone for the Treatment of Optic Neuritis

Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

Disease Activity in Pregnant and Postpartum Women with Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies

Prognostic significance of paramagnetic rim lesions in multiple sclerosis

Functional Characterisation of the Circular RNA, circHTT(2-6), in Huntington’s Disease

Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple Sclerosis

DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes

Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity

A systematic review of the symptomatic management of Lhermitte's phenomenon

Defining progression independent of relapse activity (PIRA) in adult patients with relapsing multiple sclerosis

Disability accrual in primary and secondary progressive multiple sclerosis

Incidence and Characteristics of Melanoma in Multiple Sclerosis Patients Treated With Fingolimod

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis

Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation

Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial

The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.

Cerebrospinal fluid protein

Collaborators (25)

Ai-Lan Nguyen

Vilija Jokubaitis

Lara Kular

Youichirou Ootsuka

Luke Selth

Rebecca Ormsby

Justin Yehuda Garber

Marzena Pedrini

Brett Stringer

Giovanna De Luca

Eduardo Aguera-Morales

Maria José Sá

Adil Harroud

William Brown

Lars Alfredsson

Rodney Scott

Bruce V. Taylor

francesco patti

Alessandra Lugaresi

Yi Chao Foong

Izanne Roos

Allan Kermode

Charles B. Malpas

William L Herring

Simon Conn

Make your next move.